Assessment of the anti-hepatitis B vaccination efficacy in high risk children
收藏Global Health Data Exchange ()2024-06-26 收录
数据链接：
官方服务：
资源简介：
Assessment of the anti-hepatitis B vaccination efficacy in high risk children
应用场景：
相关数据集
Physicochemical characterization of positively charged CSNC:HB prototypes.
Results are presented as mean ± SD. CSNC: chitosan nanocapsules; HB: recombinant hepatitis B surface antigen; PdI: polydispersity index; A.R.: association efficiency; n.d.: not determined.
NIAID Data Ecosystem50
ATN 025 Medical and Health History Form [CRF 3] Dataset in Hepatitis B Vaccination in Youth at Adolescent Trials Network Sites: Effectiveness of Two Strategies and Evaluation of Tools to be Used in Future HIV Prevention Trials
Data from Medical and Health History Form [CRF 3] Study Description A randomized, single-blinded trial evaluating two licensed vaccine products, Recombivax and Twinrix, given in a two-dose schedule to
NIAID Data Ecosystem40
ATN048 Quantitative HEP B Results Dataset in Correlates of HBV-Specific B Cell Memory Following Vaccination in HIV-Infected Adolescents and HIV-Uninfected Adolescents: A Substudy of ATN 024 and ATN 025
Data from Quantitative HEP B Results Study Description An exploratory laboratory-based evaluation of cellular immune response to immunization with hepatitis B surface antigen in HIV-infected and HIV-u
NIAID Data Ecosystem20
Monitoring of post-vaccination anti-HBs titles vaccine in children and adolescents in the pre-dialysis of chronic kidney disease
Abstract Introduction: Bacterial or viral diseases are one of the major causes of death in patients with chronic kidney disease (CKD). These patients show a quantitative reduction of levels of antibod
DataCite Commons2022-06-02 更新40
ATN 025 Adverse Event Evaluation Form, Version 2: Abnormal Laboratory Results [CRF 95] Dataset in Hepatitis B Vaccination in Youth at Adolescent Trials Network Sites: Effectiveness of Two Strategies and Evaluation of Tools to be Used in Future HIV Prevention Trials
Data from Adverse Event Evaluation Form, Version 2: Abnormal Laboratory Results [CRF 95] Study Description A randomized, single-blinded trial evaluating two licensed vaccine products, Recombivax and T
NIAID Data Ecosystem30
